Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > News > Nanotech Delivery Request: A Corporate Presentation from Merck Research Laboratories

April 17th, 2007

Nanotech Delivery Request: A Corporate Presentation from Merck Research Laboratories

Representatives from Merck will make a special presentation to researchers and scientists in universities and companies at the Nanotech 2007 conference on May 23, 2007 at the Santa Clara Convention Center in California.

Merck recently acquired Sirna Therapeutics, a leader in efforts to create RNAi-based therapeutics that could significantly alter the treatment of disease. RNAi-based therapeutics selectively catalyze the destruction of the RNA transcribed from an individual gene enabling an novel approach to discovering drugs with the potential to produce highly specific, potent, and long-lasting effects.


Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Sniffing out cancer with improved 'electronic nose' sensors October 2nd, 2015

Hopes of improved brain implants October 1st, 2015

New Nanomaterials Taking Research to Mexico, Possibly into Space September 29th, 2015

Cristal Therapeutics Starts Clinical Phase I Trial with Nanomedicine CriPec Docetaxel in Patients with Solid Tumours September 29th, 2015


Horizontal magnetic tunneling in a field-effect device integrated on Silicon October 2nd, 2015

Industrial Nanotech, Inc. Announces New Office in Arizona to Service the Company's New Regional and National Home Builders in Arizona and Nevada October 2nd, 2015

Production of High Temperature Ceramics with Modified Properties in Iran October 2nd, 2015

ISO Approves 2 Int'l Nanotechnology-Related Standards Proposed by Iran October 2nd, 2015


Flex-ANA workshop at NCSU: Flex-ANA: An Automated System for Nanomechanical Analysis of Soft Materials October 28 (NCSU, Raleigh, NC, US) September 30th, 2015

Nanosurf at the SYNMarburg 2015 Summer School: Nanosurf at the SYNMarburg 2015 Summer School September 30th, 2015

Arrowhead Nominates ARC-HIF2 As First RNAi Therapeutic Candidate Using Extrahepatic DPC(TM) Delivery System: Data to be presented September 27 at the European Cancer Conference 2015 in Vienna September 11th, 2015

AUREA Technology will show Quantum Dots lifetime measurement at the 14th conference on Methods and Applications of Fluorescence MAF14 September 11th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic